Science Explorer Back to mapMap
Discussion
Institution · Clover Biopharmaceuticals (China)

Most cited papers from Clover Biopharmaceuticals (China)

Clover Biopharmaceuticals (China)

What are the most cited papers from Clover Biopharmaceuticals (China)?

The most cited paper from Clover Biopharmaceuticals (China) is "Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial" (Peter Richmond, Lara Hatchuel, Min Dong et al., 2021), with 284 citations. Next come "S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates" (162) and "Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial" (113).

Showing 47 of 47 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial Peter Richmond, Lara Hatchuel, Min Dong et al. · The Lancet Open access 29 Jan 2021 284
2 S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates Joshua G. Liang et al. · Nature Communications Open access Mar 2021 162
3 Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial Lulu C Bravo et al. · The Lancet Open access 2022 113
4 Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo Haipeng Liu, Danmei Su, Jinlong Zhang et al. · Scientific Reports Open access 15 Aug 2017 93
5 Deep learning models for predicting RNA degradation via dual crowdsourcing Hannah K. Wayment-Steele et al. · Nature Machine Intelligence Open access 14 Dec 2022 59
6 Cryo-electron Microscopy Structure of S-Trimer, a Subunit Vaccine Candidate for COVID-19 Jiahao Ma, Danmei Su, Yinyan Sun et al. · Journal of Virology Open access 11 Mar 2021 47
7 A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis Xinyu Liu, Hong Zhou, Xueqin Huang et al. · The Journal of Immunology 13 Sep 2016 25
8 Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial Igor V. Smolenov, Htay Htay Han, Ping Li et al. · The Lancet Infectious Diseases Open access 18 Apr 2022 24
9 Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis Xiaofang Cui, Linmo Chang, Youwei Li et al. · Scientific Reports Open access 3 May 2018 20
10 Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine Peter Richmond, Lara Hatchuel, Filippo Pacciarini et al. · The Journal of Infectious Diseases Open access 4 Sep 2021 18
11 Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate Danmei Su et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 17 May 2021 18
12 p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells Dan Luo, Chune Yu, Jing Yu et al. · Cell Cycle Open access 8 Dec 2021 17
13 Asymmetric [3+2] Annulations of Thioaurone and Aurone Derivatives for the Construction of Spiroheterocycles Bao‐Xin Liu, Ru‐Jie Yan, Xiaoxun Li et al. · Asian Journal of Organic Chemistry 5 Mar 2021 17
14 Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19 Jiahao Ma, Danmei Su, Xueqin Huang et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 21 Sep 2020 17
15 Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines Donna M. Ambrosino, Htay Htay Han, Branda T. Hu et al. · The Journal of Infectious Diseases Open access 15 Nov 2021 15
16 Clinical and Diagnostic Findings of Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in the COVID-19 Era Elias Premi, Roberto Acampora, Davide Salmi et al. · Ophthalmologica Open access 2023 13
17 Functional Detection of TNF Receptor Family Members by Affinity-Labeled Ligands Xu Yang, Lingmo Chang, Anliang Huang et al. · Scientific Reports Open access 25 Jul 2017 13
18 Iron‐Sulfate‐Catalyzed Direct Dehydrogenative Coupling Cyanation of Secondary Phenylamines Mingming Huang, Qingfu Deng, Qin Xiang Gao et al. · Asian Journal of Organic Chemistry 22 Nov 2017 11
19 High Level Expression and Purification of Recombinant Proteins from Escherichia coli with AK-TAG Dan Luo, Caixia Wen, Rongchuan Zhao et al. · PLoS ONE Open access 23 May 2016 11
20 pKILLIN: a versatile positive-selection cloning vector based on the toxicity of Killin in Escherichia coli Zelong Ma, Dan Luo, Anliang Huang et al. · Gene 21 Apr 2014 10
21 Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents Pío López, Lulu C Bravo, Erik Buntinx et al. · Human Vaccines & Immunotherapeutics Open access 2 Jan 2023 7
22 Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study Romana Hosain, Peter Aquino, Carmen I. Baccarini et al. · Vaccine Open access 10 Feb 2023 7
23 Urine-based detection of biomarkers indicative of chronic kidney disease in a patient cohort from Ghana Wasco Wruck, Vincent Boima, Lars Erichsen et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 27 Oct 2022 7
24 [A preliminary pharmacophylogenetic study of Solanaceae medicinal plants containing tropane alkaloids]. Erhuan Zang, Qinyu Li, Jinfan Xu et al. · PubMed Sep 2021 7
25 A first-in-human evaluation of the safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19 in healthy adults; a phase 1, randomised, double-blind, placebo-controlled trial Peter Richmond, Lara Hatchuel, Min Dong et al. · medRxiv PreprintOpen access 4 Dec 2020 7
26 Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike Wonyeong Jung, Dansu Yuan, Benjamin P. Kellman et al. · npj Vaccines Open access 5 Jan 2024 6
27 Enhanced thermostability of C 2 -symmetrical bis(imino)pyridine-iron precatalysts for ethylene polymerisation via a hybrid steric strategy Shuangshuang Liu, Qiuyu Li, Qaiser Mahmood et al. · Reaction Chemistry & Engineering 2025 5
28 SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines Camilo C. Roa, Mari Rose A de Los Reyes, Eric Plennevaux et al. · Human Vaccines & Immunotherapeutics Open access 11 Jan 2024 5
29 Yogliptin monotherapy in type 2 diabetes: A 12‐week randomized, double‐blind, placebo‐controlled phase II study Xin Wang, Ying Wang, Xiaolan Yong et al. · Journal of Diabetes Open access Dec 2022 5
30 Protective effects of Panax notoginseng saponins in a rat model of severe acute pancreatitis occur through regulation of inflammatory pathway signaling by upregulation of miR-181b Ming-wei Liu, Yun-qiao Huang, Yaping Qu et al. · International Journal of Immunopathology and Pharmacology Open access 2018 4
31 Cell cycle specific distribution of killin: evidence for negative regulation of both DNA and RNA synthesis Man Qiao, Dan Luo, Yi Kuang et al. · Cell Cycle Open access 6 May 2015 4
32 Immunogenicity of SCB-2019 COVID-19 Vaccine Compared to Four Approved Vaccines Donna M. Ambrosino, Htay Htay Han, Branda T. Hu et al. · Research Square PreprintOpen access 14 Sep 2021 3
33 Alternative splicing directs two IL-20R2 isoforms and is responsible for the incomplete gene knockout via the exon I ablation Hong Zhou, Xiangfei Liu, Ruoxuan Yu et al. · Genes and Immunity 24 Mar 2016 3
34 HODD: A Manually Curated Database of Human Ophthalmic Diseases with Symptom Characteristics and Genetic Variants Towards Facilitating Quick and Definite Diagnosis Zhaotian Zhang, Qiang Tang, Qiong Wang et al. · Interdisciplinary Sciences Computational Life Sciences 30 Nov 2021 2
35 Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis Ning Zhang, Changqing Zhang, Zhihong Zeng et al. · Journal of Inflammation Research Open access May 2021 2
36 Identification and characterization of REC66, a Ty1-copia-like retrotransposon in the genome of red flower of Mirabilis jalapa L. Jiang Shun-ri, Liang Joshua, Feng Haiyan et al. · Archives of Biological Sciences Open access 24 Oct 2016 2
37 Model‐Informed Drug Development Supports Full Approval of Ibuprofen Injection in Chinese Pediatric Patients With Fever or Pain Qianxi Lou, Haiyan Zhou, Zhuokang Wang et al. · Clinical Pharmacology & Therapeutics Open access 25 Nov 2025 1
38 Base-controlled diastereoselective [3+2]-cycloaddition and Michael addition of isatin ketonitrones and chalcones to construct spiropyrrolidine oxoindoles and γ-substituted isatin ketonitrones Silu Cheng, Lan Ma, Chao Yue et al. · New Journal of Chemistry 2025 1
39 Analysis of high-molecular-weight proteins using MALDI-TOF MS and Machine Learning for the differentiation of clinically relevant Clostridioides difficile ribotypes Ana Candela, David Rodríguez‐Temporal, Mario Blázquez‐Sánchez et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 20 Jun 2024 1
40 Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice Sue Ann Costa Clemens, Lily Yin Weckx, Eveline Pı́polo Milan et al. · Vaccine Open access 17 May 2024 1
41 Protection from Omicron and other VOCs by Bivalent S-Trimer COVID-19 Vaccine Danmei Su, Xinglin Li, Xueqin Huang et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 3 May 2022 1
42 Novel cyclic suspension melt crystallization process enables green separation of D, L-menthyl benzoate enantiomers Jiantao Yan, Xin Su, Huike Gu et al. · Chemical Engineering Science 29 Aug 2026 0
43 Concise Preparation of Spiro[indazole-3,3′-pyrrolidine]-2′,5′-diones by a [3+2] Cycloaddition between α-Arylidene Diazosuccinimides and In Situ Generated Benzynes Chunjun Zhu, Peng Guo, Yulong Kuang et al. · Synlett 22 Jul 2026 0
44 Safety, Tolerability and PK Characteristics of RM301B Eye Drops: A Single-Centre, Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Zhishu Bao, Wendan Xu, Ruoyu Li et al. · Advances in Therapy 31 Mar 2026 0
45 Synergistic effects of oral inoculation with recombinant Lactobacillus plantarum NC8 Co-expressing interleukin-2, interleukin-17b and interleukin-26 on infectious bronchitis vaccination in chickens Junjie Peng, Shaohua Guo, Yanyan Liu et al. · Poultry Science Open access 30 Jan 2026 0
46 A Novel Unadjuvanted Subunit Respiratory Syncytial Virus Prefusion F Vaccine Induces Potent and Differentiated Functional Immune Responses Compared to AS01-Adjuvanted Arexvy in Older Adults Peter Richmond, Terence T -L Kwan, Christopher J. Rook et al. · Open Forum Infectious Diseases Open access 10 Dec 2025 0
47 How Do Your Packets Flow Leslie Alan Carr 2017 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.